Article Text
Commentary
Expanded benefits of curing the extrahepatic manifestations of HCV infection
Statistics from Altmetric.com
Footnotes
Contributors FN wrote the entire manuscript.
Competing interests The corresponding author has received research grant from Gilead Sciences, and is advising Merck, Gilead and AbbVie.
Patient consent Not required.
Provenance and peer review Commissioned; internally peer reviewed.